NCT05947708View on ClinicalTrials.gov

The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

October 15, 2019

Study Completion Date

January 15, 2020

Conditions
End Stage Renal Disease on Dialysis
Interventions
DEVICE

Dialysate Flow Rate

Hemodialysis is completed with dialysate being used at differing flow rates. Flow rates will be modified to see if this is a causal factor in post-dialysis recovery.

Trial Locations (1)

95112

Outset Medical, San Jose

Sponsors

Lead Sponsor

Outset Medical
All Listed Sponsors
collaborator

White Plains Hospital

OTHER

lead

Outset Medical

INDUSTRY

NCT05947708 - The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 | Biotech Hunter | Biotech Hunter